Zhu W. Roles of olive oil and physical exercise in non-alcoholic fatty liver disease after ultrasound-based evaluation. World J Hepatol 2025; 17(2): 100243 [DOI: 10.4254/wjh.v17.i2.100243]
Corresponding Author of This Article
Wei Zhu, PhD, Postdoctoral Fellow, Shanghai Xi Rong Information Science and Technology Company Limited, National Science and Technology Park, Tongji University, No. 1239 Siping Road, Yangpu District, Shanghai 200092, China. zhuwei8247@aliyun.com
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Letter to the Editor
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Hepatol. Feb 27, 2025; 17(2): 100243 Published online Feb 27, 2025. doi: 10.4254/wjh.v17.i2.100243
Roles of olive oil and physical exercise in non-alcoholic fatty liver disease after ultrasound-based evaluation
Wei Zhu
Wei Zhu, Shanghai Xi Rong Information Science and Technology Company Limited, National Science and Technology Park, Tongji University, Shanghai 200092, China
Wei Zhu, School of Life Sciences and Technology, Tongji University, Shanghai 200092, China
Author contributions: Zhu W designed the study, wrote the full manuscript, and prepared all the figure and table, as well as other related work.
Supported by the Natural Science Foundation of Shanghai, No. 17ZR1431400; and National Key Research and Development Program of China, No. 2017YFA0103902.
Conflict-of-interest statement: The author reports no relevant conflicts of interest for this article.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Wei Zhu, PhD, Postdoctoral Fellow, Shanghai Xi Rong Information Science and Technology Company Limited, National Science and Technology Park, Tongji University, No. 1239 Siping Road, Yangpu District, Shanghai 200092, China. zhuwei8247@aliyun.com
Received: August 10, 2024 Revised: January 9, 2025 Accepted: January 14, 2025 Published online: February 27, 2025 Processing time: 193 Days and 9.5 Hours
Abstract
Non-alcoholic fatty liver disease (NAFLD) without special drugs shows symptoms of liver fat accumulation and steatosis in patients without alcohol intake. Ultrasound evaluation is a critical method in the early diagnosis of NAFLD stages as well as image processing and should be encouraged. Olive oil is an important component of the Mediterranean diet and has a beneficial role in the prevention of NAFLD progression. Physical activity and exercise can have anti-oxidant and anti-inflammatory effects to reduce liver fat and body weight via regulation of mitochondrial capacity in the development of NAFLD. Both the Mediterranean diet and physical exercise should be combined to achieve the ideal fat content reduction and weight loss in patients with NAFLD.
Core Tip: This article is a response to the published paper by Zhu based on the track article quality report from an editorial board member/peer-reviewer. Olive oil in the Mediterranean diet was proposed to have an effective role in preventing non-alcoholic fatty liver disease progression. In addition, physical activity and exercise displayed a critical role in the prevention of non-alcoholic fatty liver disease development.